Quest Diagnostics - Press Releases

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996

Quest Diagnostics Declares Quarterly Cash Dividend

12/18/7

Quest Diagnostics to Speak at the Merrill Lynch Health Services Investor Conference

11/26/7

Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease

11/06/7

Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance

11/01/7

Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics

10/26/7

Quest Diagnostics Reports Third Quarter Results

10/24/7

Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI)

10/09/7

Quest Diagnostics to Speak at the 2007 UBS Global Life Sciences Conference

09/21/7

Quest Diagnostics Again Selected as Part of Dow Jones Sustainability World and North American Indexes

09/10/7

Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference

09/10/7

Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children

08/30/7

Quest Diagnostics Declares Quarterly Cash Dividend

08/17/7

Quest Diagnostics Drug Testing Index(R) Finds Cocaine Use at 10-Year Low Among U.S. Workers

08/09/7

Quest Diagnostics Reports Second Quarter 2007 Results

07/24/7

Quest Diagnostics Announces New Testing Technique for Improved Diagnosis of Metabolic And Nutritional Disorders

07/19/7

Quest Diagnostics Launches National Patient Appointment Scheduling

07/17/7

Diabetes Patients Make Significant Gains in Disease Control; Still, Nearly Half Fail to Reach ADA Treatment Goals

06/23/7

Quest Diagnostics to Speak at the Jefferies Healthcare Conference

06/22/7

Quest Diagnostics Announces Pricing of Senior Notes

06/20/7

Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering

06/19/7

Quest Diagnostics Incorporated Announces Completion of Tender Offer for the 10 1/2% Senior Subordinated Notes Due 2013 of AmeriPath, Inc.

06/19/7

Quest Diagnostics Extends Agreement With CIGNA Healthcare

06/07/7

Quest Diagnostics Incorporated Announces Pricing and Receipt of Requisite Consents for Cash Tender Offer and Consent Solicitation for the 10 1/2% Senior Subordinated Notes Due 2013 of AmeriPath, Inc.

06/05/7

Quest Diagnostics Completes Acquisition of AmeriPath

05/31/7

Quest Diagnostics Plans to Complete Acquisition of AmeriPath on May 31

05/30/7

Quest Diagnostics to Speak at the Bank of America Healthcare Conference 2007

05/29/7

Study Reports Point-of-Care Test to be as Accurate as Conventional Laboratory Analysis in Detecting Kidney Disease in Patients with Diabetes and Cardiovascular Disease

05/21/7

Quest Diagnostics Commences Cash Tender Offer for AmeriPath 10 1/2% Senior Subordinated Notes Due 2013

05/21/7

Award for 'Best Employer for Healthy Lifestyles' Given to Quest Diagnostics

05/10/7

Quest Diagnostics Declares Quarterly Cash Dividend

05/08/7

Quest Diagnostics Reports First Quarter 2007 Results

04/19/7

Quest Diagnostics' MedPlus(R) Subsidiary Selected To Develop The Lab Information System For The Province of British Columbia's Electronic Health Record System

04/17/7

Quest Diagnostics to Acquire AmeriPath in a Transaction Valued at $2 Billion

04/16/7

Quest Diagnostics Selected as Sole Laboratory Service Provider to National Health Service Hospital and Primary Care Trust

03/22/7

Quest Diagnostics to Speak at the Lehman Brothers Tenth Annual Healthcare Conference

03/15/7

Drug Use Hits New Low Among U.S. Workers in 2006, According to Quest Diagnostics' Drug Testing Index(R)

03/07/7

Focus Diagnostics Receives FDA Clearance to Market Plexus HerpeSelect

03/05/7

MedPlus' ChartMaxx(R) Earns Top Ranking in the '2006 Top 20 Year-End Best in KLAS' Report for Third Consecutive Year

02/22/7

National Survey Shows Physicians Have Clear Preference Between the Two Largest Diagnostic Laboratories

02/14/7

Quest Diagnostics Declares Quarterly Cash Dividend

02/13/7

Quest Diagnostics Acquires HemoCue for Approximately $420 Million, Entering Market for Near Patient Testing

02/01/7

Quest Diagnostics to Speak at Wachovia Securities 2007 Healthcare Conference

01/29/7

Quest Diagnostics Reports Strong Results for Fourth Quarter and Full Year 2006

01/25/7

Quest Diagnostics Announces Licensing Agreement for Genetic Testing Technology to Screen for Most Common Inherited Mental Impairment, Fragile X Syndrome

01/19/7

Quest Diagnostics to Speak at the 25th Annual JPMorgan Healthcare Conference

01/09/7